Hikal Ltd.

NSE: HIKAL | BSE: 524735 | ISIN: INE475B01022 | Industry: Pharmaceuticals
| Mid-range Performer
359.4500 -0.30 (-0.08%)
NSE Jun 20, 2025 15:31 PM
Volume: 128.6K
 

logo
Hikal Ltd.
19 Sep 2018, 12:00AM
359.45
-0.08%
ICICI Securities Limited
We met the management of Hikal Ltd (Hikal) to gain an insight into the company's pharma and agrochem businesses. Established in 1988, Hikal is a B2B player, which provides active ingredients, intermediates and R&D; services to global pharmaceuticals, animal health, crop protection and specialty chemicals companies. For FY18, pharma and agrochem accounted for 58% and 42%, respectively, of total operating revenues. The pharma business is currently divided almost equally between generic active pharma ingredients (APIs) and contract research and...
Hikal Ltd. is trading below all available SMAs
More from Hikal Ltd.
Recommended